Posted: Tue Oct 16, 2007 10:03 pm Post subject: Can Ancient Herbs Treat Cancer?
Can Ancient Herbs Treat Cancer?
The Chinese herb Ban Zhi Lian may not be in everyone's lexicon but to the 80 women with stage IV metastatic breast cancer, who are participating in the second phase of the BZL101 clinical trials, it represents hope and life.
For Bionovo, the drug discovery and development company in Emeryville, Calif., that's behind BZL101, there's hope too. The trial is the first FDA-validated clinical study of a potential cancer drug derived from a Chinese medicinal herb, says Dr. Mary Tagliaferri, a co-founder of the company, former practicing acupuncturist and a breast-cancer survivor. "Sixty-two percent of chemotherapy drugs come from natural products, and plants have been the basis of almost every new class of medication," she says. "It makes sense that these plants can act as anticancer agents."
Tagliaferri's interest in Ban Zhi Lian, which has traditionally been used to treat swellings, sores and fever, was sparked in 1996 by a fellow acupuncturist, Isaac Cohen, who would later become a co-founder of Bionovo. At that time, Cohen had been treating, for a decade, women who were battling breast cancer with conventional medicines and had run out of treatment options. "In their exhaustion and desperation, they were trying to find an alternative treatment that was not so harsh," says Cohen, who often prescribed herbs to be prepared as teas to ease the side effects of chemo and hormone therapy. But the patients' oncologists, says Cohen, discouraged them from trying anything new. "They'd say Chinese medicine was quackery and that there was no evidence it worked," he says. Still, Cohen observed that many of the women to whom he gave Chinese herbs, including Ban Zhi Lian, responded well to the herbs and even experienced a relatively good quality of life. "At first I chucked it to luck," he says. "But then you see it's not just luck. And then you ponder why."
Cohen's early observations about Ban Zhi Lian may have started out as a hunch, but they may hold up. In 1996, Cohen and Tagliaferri, along with Dr. Debu Tripathy, then a breast cancer specialist at the University of California, San Francisco, co-founded the Complementary and Alternative Medicine program at the university's Carol Franc Buck Breast Care Center. Over the next several years, the trio amassed enough evidence about the herb's anticancer properties — in lab tests of animals and breast-cancer cells, BZL101 caused apoptosis or cell death, according to Tagliaferri — to get a green light from the FDA to begin clinical trials.
The researchers conducted Phase I trials at Buck and at the Cancer Research Network in Plantation, Fla. Their 21 participants had stage IV metastatic breast cancer, which had continued to progress despite an average of four rounds of standard treatment, including chemo and hormone therapy. The patients took 12 g a day of Ban Zhi Lian, a dose that's three times more concentrated than the amount found in a cup of brewed tea. After about a year, 25% of the patients saw stabilization in their disease for 90 days, and 19% for 180 days. The experimenters say BZL101 works by preventing cancer cells from undergoing glycolysis, a process of glycogen breakdown that accounts for as much as 85% of cancer cells' energy supply.
In 2002, Tagliaferri and Cohen left Buck to establish Bionovo, where they began Phase II trials of BZL101 in April 2006, expanding their studies to 10 hospitals and breast cancer centers, including the University of Chicago Medical Center, Duke University Medical Center and the M.D. Anderson Cancer Center in Houston. Bionovo expects the second phase of trials to conclude by early 2008.
Women with breast cancer have typically sought Chinese medical herbalists for relief from the side effects of chemotherapy and radiation or to strengthen and balance their immune systems; some have even hoped for a cure. Some women may have been helped; others not. But with so many variables — the broad range of patients, quality and potency of the herbs available, types of formulations prescribed and the expertise of the herbalist — outcomes in informal settings were never a sure thing. And it's the same kind of variability that has made clinical research so problematic. "Even though people are very interested in herbal therapy and a lot of people take herbs, research in herbal therapy is difficult because you're dealing with a mixture of compounds," says Tripathy, who is now a clinical professor of internal medicine at the University of Texas Southwestern Medical Center in Dallas. During the research phase, Tripathy says, scientists often attempt to isolate one particular molecule or compound from the herbal extract — and the anticancer activity is lost. "There are herbal extracts in which the anticancer activity is actually due to the synergy between many of the compounds contained in that extract," he says.
Tripathy also says that companies like Bionovo have a tough time getting funding either from the private sector or from pharmaceutical companies: "In the absence of controlled clinical trials, people are skeptical and say 'There's no evidence this works,'" he says. Bionovo, which expects to begin Phase III trials in 2009, hopes to upset this way of thinking. And, says Tagliaferri, the company is studying about two dozen other Chinese herbs with anticancer potential.
The FDA at least is eager to see more studies of botanical treatments of cancer. "We're not opposed to Chinese medicine," says Dr. Shaw Chen, botanical review team leader at the FDA. "We just like to see clinical studies that meet our standards." Chen agrees it can be tough to study the pharmacological activity of botanical compounds or to ensure consistency in quality, but Bionovo's efforts, if fruitful, may help pave the way for other research. "A successful application to market for a cancer drug based on Chinese medicine will be encouragement to the industry," he says. "I think the industry is watching for the first success story."
i come across a site with a product of ayurveda 100% fully extract, the combinations of various herbs give tremendous results.
here is info abt the product:
AV METACARE is a innovative herbal preparation that addresses the spread of cancerous cells or matastasis. It has two modes of action:
AV METACARE is prepared from selected herbs based on years of research. These herbs have immunomodulatory properties and check the spread of cancerous cells by binding to the E-cadherin protein’s external surface thereby blocking the adhesion of the cancerous cell to good tissue. This process inhibits the spread of cancer and the activity of the herbs in modulating the immune system ensures that the body natural defenses allow the various bio chemical changes in the body to return to normal. The antioxidant capacity of herbs has been recognized by the international medical community as playing a significant role in the protection against cancer as well as in checking the spread of cancer by acting as “free radical scavengers”.
AV METACARE is a unique product as it addresses both issues of protecting normal cells from being targeted by cancer cells.
Manufacturee info:
Amsar Pvt. Ltd.
Indore, Madhya Pradesh, India
In 1963, Amsar Private Limited set up Asia’s first integrated Botanical extraction facility for the production of standardized extracts. For nearly 40 years, Amsar has been at the forefront of the Asian Industry setting new standards of quality along the way. A Unique discovery platform has enabled us to focus on the ethnomedical usage of botanicals with potential therapeutic activity. Over 200 plants have been standardized and produced in India’s first GMP certified production facility. Again, we have raised the bar by being the only manufacturer with two GMP certificates, one for botanical extracts and the other for Pharmacopoeial extracts.
Amsar has a fully certified QC laboratory screens every herb prior to its release for production and thereafter a battery of Quality tests guarantee that the final product is of the highest standard. In-house microbiological assays and heavy metal assays that conform to USP specifications guarantee safety of the products supplied. Chromatographic fingerprinting confirms “full spectrum”. A unique “isolated clean room” sieving & filling program ensures that our products are handled with the greatest care.
Amsar represents a truly unique experience in modern herbal production by combining ethnomedicine and modern scientific tools. Validating ethnomedical claims of traditional healers and developing processes to manufacture high quality botanical derivatives form a part of our Research & Development Program.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
Note: Your messages are your words, you are entirely responsible and liable for the content of your messages, as well as your overall behavior as a member of the PJNet community. Although the administrators and moderators of PJNet Forums will attempt to keep all objectionable messages off this forums, it is impossible for us to review all messages. All messages express the views of the author, and neither the owners of PJNet Forums, nor ViNSiGN will be held responsible for the content of any message.
You can syndicate the last 10 posted messages in Petaling Jaya Malaysia Forums using the file backendforums.php
